Related references
Note: Only part of the references are listed.Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V. Marino et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
The Apoptosis Paradox in Cancer
Ornella Morana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
(-)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
I-Ta Lu et al.
MARINE DRUGS (2022)
Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
Jianhua Jiao et al.
Aging-US (2022)
Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma
Xun Liu et al.
CANCER SCIENCE (2022)
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia
Miyoung Lee et al.
NATURE COMMUNICATIONS (2022)
The cross-talk of autophagy and apoptosis in breast carcinoma: implications for novel therapies?
Kamil Seyrek et al.
BIOCHEMICAL JOURNAL (2022)
Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Wenxi Zhou et al.
BIOMATERIALS (2021)
Current treatment and recent progress in gastric cancer
Smita S. Joshi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Galectin-9 as a biomarker of disease severity
Preeti Moar et al.
CELLULAR IMMUNOLOGY (2021)
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
Riyao Yang et al.
NATURE COMMUNICATIONS (2021)
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
Bailey B. Blair et al.
CANCERS (2021)
Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis
Yang An et al.
FRONTIERS IN MEDICINE (2021)
Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
Asahiro Morishita et al.
ONCOLOGY REPORTS (2021)
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Sashi Kandel et al.
CANCER LETTERS (2021)
Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia
Nannan Pang et al.
FASEB JOURNAL (2021)
Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer
S. H. Petersen et al.
SCIENTIFIC REPORTS (2021)
A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)
Kohei Takizawa et al.
GASTRIC CANCER (2021)
Recent progress in multidisciplinary treatment for patients with esophageal cancer
Masayuki Watanabe et al.
SURGERY TODAY (2020)
Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer
Ryu Ishihara et al.
DIGESTIVE ENDOSCOPY (2020)
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
Adrian M. Seifert et al.
ONCOGENE (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Prognostic role of galectins expression in patients with hepatic cancer A meta-analysis
Qi Shao et al.
MEDICINE (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Personalized Adjuvant Treatment of Colon Cancer
Hossein Taghizadeh et al.
VISCERAL MEDICINE (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
Fei Kong et al.
PEERJ (2020)
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2019)
Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
Taiga Chiyo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
Kostandinos Sideras et al.
SCIENTIFIC REPORTS (2019)
The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
Inna M. Yasinska et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hsp60 and IL-8 axis promotes apoptosis resistance in cancer
Sandeep Kumar et al.
BRITISH JOURNAL OF CANCER (2019)
Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis
Qiqing Sun et al.
CANCER CELL INTERNATIONAL (2019)
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
Bettina Langhans et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Metabolic Regulation of Macrophage Polarization in Cancer
Kamiya Mehla et al.
TRENDS IN CANCER (2019)
Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection
Yong Zhang et al.
JOURNAL OF CANCER (2019)
Role of Galectins in Tumors and in Clinical Immunotherapy
Feng-Cheng Chou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Shaofei Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk
Carlos A. Orozco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
Xiaoxiang Zhou et al.
FRONTIERS IN PHYSIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Patients With Pancreatic Ductal Adenocarcinoma Have High Serum Galectin-9 Levels: A Sweet Molecule to Keep an Eye On
Lucas B. Tavares et al.
PANCREAS (2018)
BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1β Maturation in Macrophages
Dhruv Chauhan et al.
CELL REPORTS (2018)
Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer
Kostandinos Sideras et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study
Tomoko Tadokoro et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Regulation of M1-type and M2-type macrophage polarization in RAW264.7 cells by Galectin-9
Ran Lv et al.
MOLECULAR MEDICINE REPORTS (2017)
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
Donnele Daley et al.
NATURE MEDICINE (2017)
Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells
Emiko Akashi et al.
ONCOLOGY REPORTS (2017)
Prognostic value of tumoral expression of galectin-9 in gastric cancer
Sang Il Choi et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2017)
miR-455-5p functions as a potential oncogene by targeting galectin-9 in colon cancer
Qianqian Yang et al.
ONCOLOGY LETTERS (2017)
Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma
Anfeng Si et al.
ONCOTARGET (2017)
PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
Kostandinos Sideras et al.
ONCOIMMUNOLOGY (2017)
DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
Varun Sasidharan Nair et al.
CLINICAL EPIGENETICS (2017)
Galectin-9 suppresses the proliferation of gastric cancer cells in vitro
Jitsuko Takano et al.
ONCOLOGY REPORTS (2016)
Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives
Joanne Chia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Mechanisms of disease: The human N-glycome
Gordan Lauc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
IMMUNOTHERAPY PD-1 says goodbye, TIM-3 says hello
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway
Yang Wang et al.
PLOS ONE (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Pancreatic Cancer: Pathogenesis and Diagnosis
Vedat Goral
Asian Pacific Journal of Cancer Prevention (2015)
Comparative structural analysis of the caspase family with other clan CD cysteine peptidases
Karen McLuskey et al.
BIOCHEMICAL JOURNAL (2015)
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
Koji Fujita et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer
Qianqian Yang et al.
ONCOLOGY REPORTS (2015)
Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest
Kiyoyuki Kobayashi et al.
ONCOLOGY REPORTS (2015)
Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer
Dong Tang et al.
TUMOR BIOLOGY (2015)
Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells
Dhafer Mrizak et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Equol induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells through the intrinsic pathway and the endoplasmic reticulum stress pathway
Xiao-Lin Liang et al.
ANTI-CANCER DRUGS (2014)
Changed Expression of E-cadherin and Galectin-9 in Oral Squamous Cell Carcinomas but Lack of Potential as Prognostic Markers
Siew Wui Chan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Intracellular galectins in cancer cells: Potential new targets for therapy ( Review)
Maria C. Vladoiu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer
Jiaxing Yang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Current Innovations in Endoscopic Therapy for the Management of Colorectal Cancer: From Endoscopic Submucosal Dissection to Endoscopic Full-Thickness Resection
Shintaro Fujihara et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Crosstalk between apoptosis, necrosis and autophagy
Vassiliki Nikoletopoulou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
A Unique Galectin Signature in Human Prostate Cancer Progression Suggests Galectin-1 as a Key Target for Treatment of Advanced Disease
Diego J. Laderach et al.
CANCER RESEARCH (2013)
Glycobiology of cell death: when glycans and lectins govern cell fate
R. G. Lichtenstein et al.
CELL DEATH AND DIFFERENTIATION (2013)
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis
Jayshree Mishra et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice
Lucy Golden-Mason et al.
JOURNAL OF VIROLOGY (2013)
Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
Jing Jiang et al.
PLOS ONE (2013)
Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma
Maria L. Bacigalupo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
Zhao-Yang Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells
N. Mazurek et al.
CELL DEATH AND DIFFERENTIATION (2012)
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2012)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3+ Treg Development by Galectin-9 Secretion
Souichi Oomizu et al.
PLOS ONE (2012)
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
Qing Zhou et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Galectin multimerization and lattice formation are regulated by linker region structure
Lesley A. Earl et al.
GLYCOBIOLOGY (2011)
GDP-mannose-4,6-dehydratase (GMDS) Deficiency Renders Colon Cancer Cells Resistant to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor- and CD95-mediated Apoptosis by Inhibiting Complex II Formation
Kenta Moriwaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Liver Membrane Proteome Glycosylation Changes in Mice Bearing an Extra-hepatic Tumor
Albert Lee et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity
Yurong Li et al.
MOLECULAR IMMUNOLOGY (2011)
Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation
Olga M. Shatnyeva et al.
PLOS ONE (2011)
X-ray Structures of Human Galectin-9 C-terminal Domain in Complexes with a Biantennary Oligosaccharide and Sialyllactose
Hiromi Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia
Junya Kuroda et al.
MOLECULAR CANCER RESEARCH (2010)
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
T. Kobayashi et al.
LEUKEMIA (2010)
SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity
E. Charlier et al.
LEUKEMIA (2010)
Lectin Microarrays for Glycomic Analysis
Garima Gupta et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2010)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
Deficiency of GMDS Leads to Escape from NK Cell-Mediated Tumor Surveillance Through Modulation of TRAIL Signaling
Kenta Moriwaki et al.
GASTROENTEROLOGY (2009)
The galectin profile of the endothelium - Altered expression and localization in activated and tumor endothelial cells
Victor L. Thijssen et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Identification of Galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain
M. A. Mayoral et al.
CANCER INVESTIGATION (2008)
Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices
Atsuya Nobumoto et al.
GLYCOBIOLOGY (2008)
Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways
Shuguang Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Regulation of glycan structures in animal tissues - Transcript profiling of glycan-related genes
Alison V. Nairn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Jessica Plati et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Bcl-2-regulated apoptosis: mechanism and therapeutic potential
Jerry M. Adams et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes
Yuka Tsuboi et al.
CLINICAL IMMUNOLOGY (2007)
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
Cecile Keryer-Bibens et al.
BMC CANCER (2006)
The sweet and sour of cancer: Glycans as novel therapeutic targets
MM Fuster et al.
NATURE REVIEWS CANCER (2005)
Development of highly stable galectins: Truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins
N Nishi et al.
FEBS LETTERS (2005)
Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitochondrial hyperpolarization, budding, and fission
P Matarrese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness - Poor prognosis in patients with pancreatic ductal adenocarcinoma
S Ueda et al.
PANCREAS (2004)
Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways
T Fukumori et al.
CANCER RESEARCH (2004)
Mechanisms of caspase activation
KM Boatright et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Selective eosinophil adhesion to fibroblast via IFN-γ-induced galectin-9
A Hirofumi et al.
JOURNAL OF IMMUNOLOGY (2002)
Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions
CF Brewer et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2002)
Ah, sweet mystery of death! Galectins and control of cell fate
JD Hernandez et al.
GLYCOBIOLOGY (2002)
Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance
T Kageshita et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas
B Terris et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Regulation of galectin-9 expression and release in Jurkat T cell line cells
S Chabot et al.
GLYCOBIOLOGY (2002)
Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity
M Sato et al.
GLYCOBIOLOGY (2002)
Galectin-9 in physiological and pathological conditions
M Hirashima et al.
GLYCOCONJUGATE JOURNAL (2002)
Molecular and functional characterization of galectin 9 mRNA isoforms in porcine and human cells and tissues
F Spitzenberger et al.
BIOCHIMIE (2001)
Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter
MS Lipkowitz et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Intracellular functions of N-linked glycans
A Helenius et al.
SCIENCE (2001)
Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction
N Matsushita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
